Eurobio Scientific
GenDx
HLA-KMR®
HLA loss detection assays
Available as RUO
Benefits
- Detect HLA loss, Co-developed with hospitals of Essen and Milano, 10 different HLA markers
Description
When relapse is detected after HLA-mismatched hematopoietic stem cell transplantation (HSCT), it is important to understand whether or not it is characterized by “HLA loss”, i.e. genomic loss of the mismatched HLA, as this has important implications for the appropriate treatment options. The HLA-KMR kit contains 10 markers to detect HLA loss relapse. The 10 genomic markers are all located within HLA genes and integrated in the KMRtype/KMRtrack and KMRengine workflow. Available as RUO.
You have questions or want more information?
| Product | Status | Reactions |
|---|---|---|
| HLA-KMR® | RUO | 12 |
Our Products & Services
For the field of transplantation, the group produces reagents and software for transplant matching and chimerism monitoring and culture media for cornea graft transplants.
Eurobio Scientific manufactures prognostic genetics tests for breast cancer and prostatic cancer.
The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions.
To support the research and development field, Eurobio Scientific has a broad portfolio in Life Sciences products including cell culture media and quality controls.
